다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
AMEX
Can Fite BioPharma Ltd (CANF)
Can Fite BioPharma Ltd (CANF) 뉴스

CANF

Can Fite BioPharma (CANF)

Can Fite BioPharma Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:CANF

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/16	20:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/16	20:00	GlobeNewswire Inc.	Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/09	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/07	05:30	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/06	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/31	05:18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/31	05:18	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/31	05:16	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/31	05:15	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/29	21:46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/29	21:15	GlobeNewswire Inc.	Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/12	19:45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/09	19:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/09	08:01	GlobeNewswire Inc.	Can-Fite Announces Exercise of Warrants for Approximately $5.0 Million in Gross Proceeds	AMEX:CANF	Can Fite BioPharma Ltd
2024/07/29	20:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/07/29	20:00	GlobeNewswire Inc.	Can-Fite Provides Namodenoson Patent Update	AMEX:CANF	Can Fite BioPharma Ltd
2024/07/17	20:00	GlobeNewswire Inc.	Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on August 8	AMEX:CANF	Can Fite BioPharma Ltd
2024/07/11	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/07/11	20:00	GlobeNewswire Inc.	Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer	AMEX:CANF	Can Fite BioPharma Ltd
2024/07/01	20:00	GlobeNewswire Inc.	Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson	AMEX:CANF	Can Fite BioPharma Ltd
2024/06/28	20:00	Business Wire	Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner Vetbiolix	AMEX:CANF	Can Fite BioPharma Ltd
2024/06/24	20:00	Business Wire	Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver	AMEX:CANF	Can Fite BioPharma Ltd
2024/06/10	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/06/10	20:00	Business Wire	Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study	AMEX:CANF	Can Fite BioPharma Ltd
2024/06/08	05:15	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	AMEX:CANF	Can Fite BioPharma Ltd
2024/06/05	20:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/06/05	20:00	Business Wire	Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study	AMEX:CANF	Can Fite BioPharma Ltd
2024/05/29	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/05/29	20:00	Business Wire	Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases	AMEX:CANF	Can Fite BioPharma Ltd
2024/05/27	20:00	Business Wire	Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024	AMEX:CANF	Can Fite BioPharma Ltd

검색 관련기사 보기:AMEX:CANF

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Sterling

American Express

Gold vs US Dollar

Financial Select Sector

Health Care Select Sector

JP Morgan Chase

Deutsche Telekom (QX)

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관